ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DANIEL CIMAFRANCA M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,535Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 2094

$1.14M Total Retail Price of All Prescriptions

Rank: 61 out of 2094

564 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 564 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 564 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 15,543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
METOPROLOL TARTRATE 727 648 1 10
SIMVASTATIN 689 549 2 1
OMEPRAZOLE 549 500 3 4
FUROSEMIDE 410 384 4 6
AMLODIPINE BESYLATE 409 402 5 2
MIRTAZAPINE 400 368 6 43
WARFARIN SODIUM 398 339 7 11
LEVOTHYROXINE SODIUM 371 318 8 3
LACTULOSE 331 307 9 65
IPRATROPIUM-ALBUTEROL 309 284 10 92
ENALAPRIL MALEATE 302 261 11 25
RISPERIDONE 298 221 12 56
JANUVIA 289 233 13 35
TAMSULOSIN HCL 284 245 14 29
NOVOLIN R 258 208 15 214
LANTUS 243 216 16 66
METFORMIN HCL 238 170 17 8
INSULIN SYRINGE 235 212 18 143
OXYCODONE-ACETAMINOPHEN 228 192 S2 19 40
TRAMADOL HCL 226 197 20 33
DONEPEZIL HCL 213 206 21 20
ALCOHOL PREP PADS 209 201 10 22 364
METOPROLOL SUCCINATE 201 187 23 9
ZOLPIDEM TARTRATE 180 131 24 14
LOSARTAN POTASSIUM 179 161 25 17
FAMOTIDINE 172 153 26 34
CLOZAPINE 172 90 26 212
LEVETIRACETAM 169 129 28 78
CARVEDILOL 168 146 29 19
HALOPERIDOL 166 90 30 196
IPRATROPIUM BROMIDE 159 129 31 169
QUETIAPINE FUMARATE 154 92 32 71
BENZTROPINE MESYLATE 149 64 R 33 157
POTASSIUM CHLORIDE 148 137 34 24
FINASTERIDE 147 132 35 97
LATANOPROST 146 145 36 153
ALBUTEROL SULFATE 144 122 37 90
PLAVIX 144 133 37 38
ATORVASTATIN CALCIUM 142 126 39 5
SERTRALINE HCL 142 124 39 26
LISINOPRIL 141 113 41 7
CITALOPRAM HBR 139 102 42 47
GABAPENTIN 131 99 43 23
NIFEDIPINE ER 122 117 44 96
HYDRALAZINE HCL 122 114 44 89
OLANZAPINE 119 78 46 113
RENVELA 114 96 47 263
PANTOPRAZOLE SODIUM 112 100 48 37
ALCOHOL SWABS 110 87 49 382
DIVALPROEX SODIUM 109 59 50 69
CARBIDOPA-LEVODOPA 108 80 51 102
SEROQUEL 107 64 52 172
SENSIPAR 104 81 53 312
AMMONIUM LACTATE 102 99 54 185
DIGOXIN 102 87 54 51
PREDNISONE 102 99 54 54
GLIPIZIDE ER 94 72 57 126
NAMENDA 92 82 58 32
HEPARIN SODIUM 91 79 59 244
NOVOLOG 87 71 60 116
HUMULIN R 86 85 61 298
CLOPIDOGREL 85 67 62 22
ESCITALOPRAM OXALATE 80 80 63 46
SANTYL 80 69 63 114
DIOVAN 77 71 65 13
METOCLOPRAMIDE HCL 75 68 66 141
ISOSORBIDE MONONITRATE ER 75 66 66 57
QUINAPRIL HCL 74 71 68 123
POLYETHYLENE GLYCOL 3350 74 63 68 75
ATENOLOL 71 52 70 21
LEVOFLOXACIN 70 65 71 70
HUMALOG 65 64 72 164
ISOSORBIDE DINITRATE 64 59 73 400
AMOX TR-POTASSIUM CLAVULANATE 62 55 74 107
DIVALPROEX SODIUM ER 61 28 75 179
ADVAIR DISKUS 59 58 76 36
LABETALOL HCL 58 50 77 215
HYDROCHLOROTHIAZIDE 58 46 77 12
ACETAMINOPHEN-CODEINE 58 50 S3 77 129
MUPIROCIN 58 50 77 117
DORZOLAMIDE-TIMOLOL 57 55 81 356
PHENYTOIN SODIUM EXTENDED 57 46 81 158
TRICOR 57 39 81 99
METFORMIN HCL ER 56 44 84 67
FENTANYL 56 45 S2 84 68
AMIODARONE HCL 56 55 84 175
BRIMONIDINE TARTRATE 56 55 84 243
DEXILANT 55 53 88 124
TRAZODONE HCL 55 28 88 72
BUDESONIDE 54 54 90 228
NEXIUM 52 49 91 16
CLONIDINE HCL 52 50 91 62
ALENDRONATE SODIUM 52 52 91 30
VALPROIC ACID 52 43 91 221
DOXAZOSIN MESYLATE 51 51 95 120
GLIPIZIDE 51 48 95 82
CYMBALTA 51 46 95 61
SPIRIVA 50 40 98 60
LEVEMIR 50 21 98 241
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.